MARKET

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ
1.930
-0.070
-3.50%
Closed 16:27 06/18 EDT
OPEN
2.030
PREV CLOSE
2.000
HIGH
2.030
LOW
1.830
VOLUME
69.15K
TURNOVER
0
52 WEEK HIGH
3.210
52 WEEK LOW
0.9694
MARKET CAP
11.01M
P/E (TTM)
-0.6050
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PSTV last week (0610-0614)?
Weekly Report · 3d ago
Weekly Report: what happened at PSTV last week (0603-0607)?
Weekly Report · 06/10 09:50
Plus Therapeutics CMO Dr. LaFrance Resignation Announced
TipRanks · 06/07 21:10
PLUS THERAPEUTICS Says Greg Fuller Joins Company As Vice President Of Medical Affairs And Medical Director; Reports $3.3M Advance Payment From CPRIT
Benzinga · 06/07 11:40
PLUS THERAPEUTICS EXPANDS MANAGEMENT TEAM AND REPORTS $3.3M ADVANCE PAYMENT FROM CPRIT
Reuters · 06/07 11:30
Press Release: Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT
Dow Jones · 06/07 11:30
Press Release: Plus Therapeutics Expands -2-
Dow Jones · 06/07 11:30
AIGH CAPITAL MANAGEMENT, LLC REPORTS PASSIVE STAKE OF 9.9% IN PLUS THERAPEUTICS INC AS OF MAY 9, 2024- SEC FILING
Reuters · 06/05 11:28
More
About PSTV
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. The Company combines image-guided local beta radiation and targeted drug delivery approaches. The Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). Its radiotherapeutic candidate, rhenium (186Re) obisbemeda, is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC). The Company’s Rhenium (186Re) obisbemeda, a novel injectable radiotherapy designed to deliver targeted, high dose radiation directly into GBM tumors. Its radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is designed to treat many solid organ cancers.

Webull offers Plus Therapeutics Inc (USA) stock information, including NASDAQ: PSTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSTV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSTV stock methods without spending real money on the virtual paper trading platform.